Misplaced Pages

Stiff-person syndrome

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Qrater (talk | contribs) at 19:31, 15 February 2007 (Removed hypotheses about causation from treatment section). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 19:31, 15 February 2007 by Qrater (talk | contribs) (Removed hypotheses about causation from treatment section)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Medical condition
Stiff-person syndrome
SpecialtyNeurology Edit this on Wikidata
Frequency8e-05%

Stiff person syndrome (SPS) (or occasionally, stiff-man syndrome) is a rare neurologic disorder of unknown etiology.

History

SPS was first described by Moersch and Woltman at the Mayo Clinic in 1956 .

Postulated Causes

Because many patients with SPS have circulating antibodies to the enzyme glutamic acid decarboxylase (GAD), an autoimmune cause of the disease has been postulated. However, glutamic acid decarboxylase antibodies cannot be the sole cause, as most Type I Diabetics possess anti-GAD antibodies, yet the frequency of SPS among Type I diabetics is 1 in 10000

Symptoms and prognosis

Those with the illness experience progressive, fluctuating tonic contractions of all muscles, particularly the axial musculature. An inability to walk and general paralysis quickly follow; death usually occurs six to twelve months after diagnosis.

MRI detection of GABA in the brain have demonstrated reduced levels in stiff-person syndrome.

Treatment

Treatment is mostly palliative with muscle relaxants which enhance GABA production such as benzodiazepines, which lose their effectiveness as the illness progresses. In the absence of double-blind, placebo-controlled class A trials to determine treatment efficacy, some authorities recommend humane trials of immunosuppressive therapy, plasmapheresis or intravenous immunoglobulin infusion.

References

  • MOERSCH FP, WOLTMAN HW (1956). "Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases". Mayo Clin Proc. 31 (15): 421–7. PMID 13350379.
  • Murinson BB (2004). "Stiff-person syndrome". Neurologist. 10 (3): 131–7. PMID 15140273.

See also

External links

  1. http://www.annals.org/cgi/reprint/131/7/522.pdf Ann Intern Med. 1999;131:522-530.
Categories: